217 related articles for article (PubMed ID: 34032495)
1. Sarcopenic Obesity and its Prognostic Impact on Urological Cancers: A Systematic Review.
Stangl-Kremser J; Mari A; Lai LY; Lee CT; Vince R; Zaslavsky A; Salami SS; Fajkovic H; Shariat SF; Palapattu GS
J Urol; 2021 Oct; 206(4):854-865. PubMed ID: 34032495
[TBL] [Abstract][Full Text] [Related]
2. The impact of sarcopenic obesity on treatment outcomes in gastrointestinal cancer: A systematic review.
Dikova TS; Zatsepina AY; Fedorinov DS; Lyadov VK
Clin Nutr ESPEN; 2022 Feb; 47():135-146. PubMed ID: 35063193
[TBL] [Abstract][Full Text] [Related]
3. Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?
Kocher NJ; Jafri S; Balabhadra S; Lehman E; Gardner J; Vijay K; Sarwani N; Raman JD
Urol Oncol; 2018 Apr; 36(4):156.e17-156.e22. PubMed ID: 29276063
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
[TBL] [Abstract][Full Text] [Related]
6. Clinical Implications of Sarcopenic Obesity in Cancer.
Carneiro IP; Mazurak VC; Prado CM
Curr Oncol Rep; 2016 Oct; 18(10):62. PubMed ID: 27541923
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence Rate of Adult Sarcopenic Obesity and Correlation of Appendicular Skeletal Muscle Mass Index with Body Mass Index, Percent Body Fat, Waist-Hip Ratio, Basal Metabolic Rate, and Visceral Fat Area.
Luo X; Cai B; Jin W
Metab Syndr Relat Disord; 2023 Feb; 21(1):48-56. PubMed ID: 36318808
[No Abstract] [Full Text] [Related]
8. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
Kim J; Han SH; Kim HI
J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and prognostic value of sarcopenic obesity in patients with cancer: A systematic review and meta-analysis.
Gao Q; Hu K; Gao J; Shang Y; Mei F; Zhao L; Chen F; Ma B
Nutrition; 2022 Sep; 101():111704. PubMed ID: 35696740
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and associations of sarcopenia, obesity and sarcopenic obesity in end-stage knee osteoarthritis patients.
Liao J; Chen J; Xu W; Chen J; Liang X; Cheng Q; Tang Y; Huang W
J Health Popul Nutr; 2023 Oct; 42(1):108. PubMed ID: 37833797
[TBL] [Abstract][Full Text] [Related]
11. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review.
Donini LM; Busetto L; Bauer JM; Bischoff S; Boirie Y; Cederholm T; Cruz-Jentoft AJ; Dicker D; Frühbeck G; Giustina A; Gonzalez MC; Han HS; Heymsfield SB; Higashiguchi T; Laviano A; Lenzi A; Parrinello E; Poggiogalle E; Prado CM; Rodriguez JS; Rolland Y; Santini F; Siervo M; Tecilazich F; Vettor R; Yu J; Zamboni M; Barazzoni R
Clin Nutr; 2020 Aug; 39(8):2368-2388. PubMed ID: 31813698
[TBL] [Abstract][Full Text] [Related]
12. Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population.
Rodrigues V; Landi F; Castro S; Mast R; Rodríguez N; Gantxegi A; Pradell J; López-Cano M; Armengol M
J Gastrointest Surg; 2021 Jun; 25(6):1388-1403. PubMed ID: 32661833
[TBL] [Abstract][Full Text] [Related]
13. The trajectory of sarcopenia following diagnosis of prostate cancer: A systematic review and meta-analysis.
Kovač MB; Pavlin T; Čavka L; Ribnikar D; Spazzapan S; Templeton AJ; Šeruga B
J Geriatr Oncol; 2023 Sep; 14(7):101594. PubMed ID: 37482497
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenic obesity in cancer.
Jurdana M; Cemazar M
Radiol Oncol; 2024 Mar; 58(1):1-8. PubMed ID: 38378031
[TBL] [Abstract][Full Text] [Related]
15. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
16. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder.
Stangl-Kremser J; D'Andrea D; Vartolomei M; Abufaraj M; Goldner G; Baltzer P; Shariat SF; Tamandl D
Urol Oncol; 2019 Jun; 37(6):372-379. PubMed ID: 30578161
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life and fall risk associated with age-related body composition changes; sarcopenia, obesity and sarcopenic obesity.
Öztürk ZA; Türkbeyler İH; Abiyev A; Kul S; Edizer B; Yakaryılmaz FD; Soylu G
Intern Med J; 2018 Aug; 48(8):973-981. PubMed ID: 29665258
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia and sarcopenic obesity.
Choi KM
Korean J Intern Med; 2016 Nov; 31(6):1054-1060. PubMed ID: 27809450
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenic obesity in community-dwelling older women, determined by different diagnostic methods.
Oliveira TM; Roriz AKC; Barreto-Medeiros JM; Ferreira AJF; Ramos L
Nutr Hosp; 2019 Dec; 36(6):1267-1272. PubMed ID: 31610674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
